Cargando…
The Endless Saga of Monocyte Diversity
Cancer immunotherapy relies on either restoring or activating the function of adaptive immune cells, mainly CD8(+) T lymphocytes. Despite impressive clinical success, cancer immunotherapy remains ineffective in many patients due to the establishment of tumor resistance, largely dependent on the natu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691342/ https://www.ncbi.nlm.nih.gov/pubmed/31447834 http://dx.doi.org/10.3389/fimmu.2019.01786 |
_version_ | 1783443354554466304 |
---|---|
author | Canè, Stefania Ugel, Stefano Trovato, Rosalinda Marigo, Ilaria De Sanctis, Francesco Sartoris, Silvia Bronte, Vincenzo |
author_facet | Canè, Stefania Ugel, Stefano Trovato, Rosalinda Marigo, Ilaria De Sanctis, Francesco Sartoris, Silvia Bronte, Vincenzo |
author_sort | Canè, Stefania |
collection | PubMed |
description | Cancer immunotherapy relies on either restoring or activating the function of adaptive immune cells, mainly CD8(+) T lymphocytes. Despite impressive clinical success, cancer immunotherapy remains ineffective in many patients due to the establishment of tumor resistance, largely dependent on the nature of tumor microenvironment. There are several cellular and molecular mechanisms at play, and the goal is to identify those that are clinically significant. Among the hematopoietic-derived cells, monocytes are endowed with high plasticity, responsible for their pro- and anti-tumoral function. Indeed, monocytes are involved in several cancer-associated processes such as immune-tolerance, metastatic spread, neoangiogenesis, and chemotherapy resistance; on the other hand, by presenting cancer-associated antigens, they can also promote and sustain anti-tumoral T cell response. Recently, by high throughput technologies, new findings have revealed previously underappreciated, profound transcriptional, epigenetic, and metabolic differences among monocyte subsets, which complement and expand our knowledge on the monocyte ontogeny, recruitment during steady state, and emergency hematopoiesis, as seen in cancer. The subdivision into discrete monocytes subsets, both in mice and humans, appears an oversimplification, whereas continuum subsets development is best for depicting the real condition. In this review, we examine the evidences sustaining the existence of a monocyte heterogeneity along with functional activities, at the primary tumor and at the metastatic niche. In particular, we describe how tumor-derived soluble factors and cell-cell contact reprogram monocyte function. Finally, we point out the role of monocytes in preparing and shaping the metastatic niche and describe relevant targetable molecules altering monocyte activities. We think that exploiting monocyte complexity can help identifying key pathways important for the treatment of cancer and several conditions where these cells are involved. |
format | Online Article Text |
id | pubmed-6691342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66913422019-08-23 The Endless Saga of Monocyte Diversity Canè, Stefania Ugel, Stefano Trovato, Rosalinda Marigo, Ilaria De Sanctis, Francesco Sartoris, Silvia Bronte, Vincenzo Front Immunol Immunology Cancer immunotherapy relies on either restoring or activating the function of adaptive immune cells, mainly CD8(+) T lymphocytes. Despite impressive clinical success, cancer immunotherapy remains ineffective in many patients due to the establishment of tumor resistance, largely dependent on the nature of tumor microenvironment. There are several cellular and molecular mechanisms at play, and the goal is to identify those that are clinically significant. Among the hematopoietic-derived cells, monocytes are endowed with high plasticity, responsible for their pro- and anti-tumoral function. Indeed, monocytes are involved in several cancer-associated processes such as immune-tolerance, metastatic spread, neoangiogenesis, and chemotherapy resistance; on the other hand, by presenting cancer-associated antigens, they can also promote and sustain anti-tumoral T cell response. Recently, by high throughput technologies, new findings have revealed previously underappreciated, profound transcriptional, epigenetic, and metabolic differences among monocyte subsets, which complement and expand our knowledge on the monocyte ontogeny, recruitment during steady state, and emergency hematopoiesis, as seen in cancer. The subdivision into discrete monocytes subsets, both in mice and humans, appears an oversimplification, whereas continuum subsets development is best for depicting the real condition. In this review, we examine the evidences sustaining the existence of a monocyte heterogeneity along with functional activities, at the primary tumor and at the metastatic niche. In particular, we describe how tumor-derived soluble factors and cell-cell contact reprogram monocyte function. Finally, we point out the role of monocytes in preparing and shaping the metastatic niche and describe relevant targetable molecules altering monocyte activities. We think that exploiting monocyte complexity can help identifying key pathways important for the treatment of cancer and several conditions where these cells are involved. Frontiers Media S.A. 2019-08-06 /pmc/articles/PMC6691342/ /pubmed/31447834 http://dx.doi.org/10.3389/fimmu.2019.01786 Text en Copyright © 2019 Canè, Ugel, Trovato, Marigo, De Sanctis, Sartoris and Bronte. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Canè, Stefania Ugel, Stefano Trovato, Rosalinda Marigo, Ilaria De Sanctis, Francesco Sartoris, Silvia Bronte, Vincenzo The Endless Saga of Monocyte Diversity |
title | The Endless Saga of Monocyte Diversity |
title_full | The Endless Saga of Monocyte Diversity |
title_fullStr | The Endless Saga of Monocyte Diversity |
title_full_unstemmed | The Endless Saga of Monocyte Diversity |
title_short | The Endless Saga of Monocyte Diversity |
title_sort | endless saga of monocyte diversity |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691342/ https://www.ncbi.nlm.nih.gov/pubmed/31447834 http://dx.doi.org/10.3389/fimmu.2019.01786 |
work_keys_str_mv | AT canestefania theendlesssagaofmonocytediversity AT ugelstefano theendlesssagaofmonocytediversity AT trovatorosalinda theendlesssagaofmonocytediversity AT marigoilaria theendlesssagaofmonocytediversity AT desanctisfrancesco theendlesssagaofmonocytediversity AT sartorissilvia theendlesssagaofmonocytediversity AT brontevincenzo theendlesssagaofmonocytediversity AT canestefania endlesssagaofmonocytediversity AT ugelstefano endlesssagaofmonocytediversity AT trovatorosalinda endlesssagaofmonocytediversity AT marigoilaria endlesssagaofmonocytediversity AT desanctisfrancesco endlesssagaofmonocytediversity AT sartorissilvia endlesssagaofmonocytediversity AT brontevincenzo endlesssagaofmonocytediversity |